Antacids Market (By Dosage Form: Tablet, Liquid, Others; By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 160

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
       1.1.1. Definition of Antacids
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Antacids Market By Dosage Form
                 1.2.2.1. Global Antacids Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
                 1.2.2.2. Global Antacids Market Revenue Share By Dosage Form in 2017
                 1.2.2.3. Tablet
                 1.2.2.4. Liquid
                 1.2.2.5. Others
       1.2.3. Antacids Market By Distribution Channel
                 1.2.3.1. Global Antacids Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
                 1.2.3.2. Global Antacids Market Revenue Share By Distribution Channel in 2017
                 1.2.3.3. Retail Pharmacy
                 1.2.3.4. Hospital Pharmacy
                 1.2.3.5. Online Pharmacy
                 1.2.3.6. Others
       1.2.4. Antacids Market by Geography
                 1.2.4.1. Global Antacids Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.4.2. North America Antacids Market Revenue and Growth Rate (2015-2026)
                 1.2.4.3. Europe Antacids Market Revenue and Growth Rate (2015-2026)
                 1.2.4.4. Asia-Pacific Antacids Market Revenue and Growth Rate (2015-2026)
                 1.2.4.5. Latin America Antacids Market Revenue and Growth Rate (2015-2026)
                 1.2.4.6. Middle East and Africa (MEA) Antacids Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Antacids Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Antacids Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Antacids Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Antacids Major Manufacturers in 2017

CHAPTER 4. ANTACIDS MARKET BY DOSAGE FORM

4.1. Global Antacids Revenue By Dosage Form
4.2. Tablet
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Liquid
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANTACIDS MARKET BY DISTRIBUTION CHANNEL

5.1. Global Antacids Revenue By Distribution Channel
5.2. Retail Pharmacy
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hospital Pharmacy
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Online Pharmacy
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
       5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ANTACIDS MARKET BY COUNTRY

6.1. North America Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
       6.3.1. U.S. Antacids Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.4. Canada
       6.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.5. Mexico
       6.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ANTACIDS MARKET BY COUNTRY

7.1. Europe Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
       7.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4. Germany
       7.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.5. France
       7.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.6. Spain
       7.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.7. Rest of Europe
       7.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       7.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ANTACIDS MARKET BY COUNTRY

8.1. Asia-Pacific Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
       8.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4. Japan
       8.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5. India
       8.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6. Australia
       8.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7. South Korea
       8.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
       8.8.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       8.8.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ANTACIDS MARKET BY COUNTRY

9.1. Latin America Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
       9.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4. Argentina
       9.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5. Rest of Latin America
       9.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST ANTACIDS MARKET BY COUNTRY

10.1. Middle East Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
         10.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4. UAE
         10.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5. Rest of Middle East
         10.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA ANTACIDS MARKET BY COUNTRY

11.1. Africa Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Antacids Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
         11.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         11.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4. Egypt
         11.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         11.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5. Rest of Africa
         11.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
         11.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Procter & Gamble
         12.1.1. Company Snapshot
         12.1.2. Overview
         12.1.3. Financial Overview
         12.1.4. Product Portfolio
         12.1.5. Key Developments
         12.1.6. Strategies
12.2. laxoSmithKline plc
         12.2.1. Company Snapshot
         12.2.2. Overview
         12.2.3. Financial Overview
         12.2.4. Product Portfolio
         12.2.5. Key Developments
         12.2.6. Strategies
12.3. Pfizer Inc.
         12.3.1. Company Snapshot
         12.3.2. Overview
         12.3.3. Financial Overview
         12.3.4. Product Portfolio
         12.3.5. Key Developments
         12.3.6. Strategies
12.4. Bayer AG
         12.4.1. Company Snapshot
         12.4.2. Overview
         12.4.3. Financial Overview
         12.4.4. Product Portfolio
         12.4.5. Key Developments
         12.4.6. Strategies
12.5. Takeda Pharmaceutical Company Limited
         12.5.1. Company Snapshot
         12.5.2. Overview
         12.5.3. Financial Overview
         12.5.4. Product Portfolio
         12.5.5. Key Developments
         12.5.6. Strategies
12.6. BoehringerIngelheim International GmbH
         12.6.1. Company Snapshot
         12.6.2. Overview
         12.6.3. Financial Overview
         12.6.4. Product Portfolio
         12.6.5. Key Developments
         12.6.6. Strategies
12.7. Sun Pharmaceuticals Ltd.
         12.7.1. Company Snapshot
         12.7.2. Overview
         12.7.3. Financial Overview
         12.7.4. Product Portfolio
         12.7.5. Key Developments
         12.7.6. Strategies
12.8. Dr. Reddy’s Laboratories Ltd.
         12.8.1. Company Snapshot
         12.8.2. Overview
         12.8.3. Financial Overview
         12.8.4. Product Portfolio
         12.8.5. Key Developments
         12.8.6. Strategies
12.9. Reckitt Benckiser Group plc
         12.9.1. Company Snapshot
         12.9.2. Overview
         12.9.3. Financial Overview
         12.9.4. Product Portfolio
         12.9.5. Key Developments
         12.9.6. Strategies
12.10. Sanofi
          12.10.1. Company Snapshot
          12.10.2. Overview
          12.10.3. Financial Overview
          12.10.4. Product Portfolio
          12.10.5. Key Developments
          12.10.6. Strategies
12.11. Others
          12.11.1. Company Snapshot
          12.11.2. Overview
          12.11.3. Financial Overview
          12.11.4. Product Portfolio
          12.11.5. Key Developments
          12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
         13.1.1. Initial Data Search
         13.1.2. Secondary Research
         13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary